Tumor Immune Microenvironment Characterization of Primary Lung Adenocarcinoma and Lymph Node Metastases

Figure 5

Expressions of CORO1A and S100A8 in primary and metastatic lymph nodes characterize tumor recurrence. (a) Shared DEGs in primary cancer and metastatic lymph node samples. (b, c) Patients () who had transcriptome data from matched primary cancer and metastatic lymph node samples were subjected to Kaplan–Meier survival analysis. PFS survival of these patients was stratified by expression levels of CORO1A (b) and S100A8 (c). (d, e) Expression levels of CORO1A and S100A8 in primary cancer and metastatic lymph nodes in each patient within the ER and LR subgroups. (f, g) Average expression levels of CORO1A and S100A8 in primary cancer and metastatic lymph nodes in ER and LR patients.

(a)

(b)

(c)

(d)

(e)

(f)

(g)